Publications, Peer Reviewed:

Mintz M, Epstein LG, Koenigsberger MR. Neurological manifestations of acquired immunodeficiency syndrome (AIDS) in children. International Pediatrics 1989;4:161-171.

Mintz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR, Denny T, Epstein LG. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. American Journal of Diseases of Children 1989;143:771-774.

Haiken H, Hernandez M, Mintz M, Boland M. School aged HIV-infected children and access to education. Pediatric AIDS and HIV Infection: Fetus To Adolescent 1991;2:74-79.

Mintz M, Epstein LG, Koenigsberger MR. Idiopathic childhood stroke is associated with human leukocyte antigen (HLA)-B51. Annals of Neurology 1992;31:675-677.

Tudor-Williams G, St. Clair MH, McKinney RE, Maha M, Walter E, Santacroce S, Mintz M, O'Donnell K, Rudoll T, Vavro CL, Connor EM, Wilfert CM. HIV-1 sensitivity to zidovudine and clinical outcome in children. Lancet 1992;339:15-19.

Mintz M, Epstein LG. Neurologic manifestations of pediatric acquired immunodeficiency syndrome: clinical features and therapeutic approaches. Seminars in Neurology 1992;12:51-56.

Working Group On Antiretroviral Therapy (Includes Mintz M), National Pediatric HIV Resource Center: Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Pediatric Infectious Disease Journal 1993;12:513-522.

Koenigsberger MR, Lastra C, Mintz M. Manifestaciones neurologicas del virus del sida en ninos (Neurologic manifestations of AIDS in children). Acta Neuropediatrica 1994;1:28-42.

Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994;44:474-481.

Mintz M. Clinical comparison of adult and pediatric neuroAIDS. Advances in Neuroimmunology 1994;4:207-221.

Mintz M, Boland M, O'Hara MJ, Barros J, Hansen C, Maha-Elkins M, Sandzhieva D, Esenova V, Du Boisrouvray A, Oleske J. Pediatric HIV infection in Elista, Russia: interventional strategies. American Journal of Public Health 1995;85:586-588.

Mintz M. Carnitine in HIV/AIDS. Journal of Child Neurology 1995;10(Supplement No. 2):S40- S44.

Travis SF, Greenbaum BH, Mintz M, White RH, Stein S, Steckler RE, Hirsch KH, Donaldson MH. Epidural hematoma of the cauda equina in a child with hemophilia A. Journal Of Pediatric Hematology/Oncology 1996;18:308-310.

Mintz M. Neurological and developmental problems in pediatric HIV infection. Journal of Nutrition 1996;126(Suppl):S2663-S2673.

Mintz M, Tardieu M, Hoyt L, McSherry G, Mendelson J, Oleske JM. Levodopa therapy improves motor function in HIV-infected children. Neurology 1996;47:1583-1585.

DaCunha A, Mintz M, Eiden LE, Sharer LR. A neuronal and neuroanatomical correlate of HIV- 1 encephalopathy relative to HIV-1 encephalitis in HIV-1-infected children. Journal of Neuropathology and Experimental Neurology 1997;56:974-987.

Working Group on Antiretroviral Therapy and Medical Management of HIV Infected Infants, Children, and Adolescents (Mintz M is a contributing author): Antiretroviral therapy and medical management of pediatric HIV infection. Pediatrics 1998;102(suppl):1005-1062.

Raskino C, Pearson D, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M, Nozyce M, Brouwers P, McKinney RE, Jimenez E, Englund JA. Neurological, neurocognitive and brain growth outcomes in HIV-infected children receiving different nucleoside antiretroviral regimens. Pediatrics 1999;104(3):e32.

Mintz M. Clinical features and treatment interventions for HIV-associated neurologic disease in children. Seminars in Neurology 1999;19:165-176.

Mintz M. Pediatric NeuroAIDS; Continuum (a program of the American Academy of Neurology) 2000;6(5):81-110.

Mintz M. Metabolic acidosis induced by topiramate: response to bicarbonate supplementation. Advanced Studies in Medicine 2001;1(7):277-278.

Lin Liang GS, de Miguel M, Gómez-Hernández JM, Glass JD, Scherer SS, Mintz M, Barrio LC, Fischbeck KH. Severe Neuropathy with Leaky Connexin32 Hemichannels. Annals of Neurology 2005;57(5):749-54.

Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, Winner PK, Dunn DW, Dure LS, Sallee FR, Milton DR, Mintz M, Ricardi RK, Erenberg G, Layton LL, Feldman PD, Kelsey DK, Spencer TJ: Atomoxetine Treatment in Children and Adolescents with ADHD and Comorbid Tic Disorders. Neurology 2005;65(12): 1941-1949.

Spencer TJ, Sallee FR, Gilbert DL, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Milton DR, Feldman PD, Kelsey DK, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M: Atomoxetine for treatment of ADHD in children with comorbid Tourette Syndrome. Journal of Attention Disorders 2008;11(4):470-481.

Mintz M, LeGoff D, Scornaienchi J, Brown M, Allen S, Mintz P, Smith C: The Under-recognized Epilepsy Spectrum: The Effects of Levetiracetam on Neuropsychological Functioning in Relation to Subclinical Spike Production. Journal of Child Neurology. Prepublished February 2, 2009, doi:10.1177/0883073808330762

Contributions to Peer-Reviewed Publications, Participation Cited But Not By Authorship:

McKinney RE, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P, O'Donnell K, Gelber RD, Rogers GK, Lehrman SN, Wilfert CM, Protocol 043 Study Group (Includes Mintz M). A Multicenter Trial Of Oral Zidovudine In Children With Advanced Human Immunodeficiency Virus Disease. New England Journal of Medicine 1991;324:1018-1025.

National Institute of Neurologic Diseases and Stroke/Johns Hopkins University: HIV Neurologic Therapy Workshop (Mintz M participant in workshop). Journal of Neurovirology 1996.

Working Group on Antiretroviral Therapy and Medical Management of HIV Infected Children (Mintz M member). Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR, 1997.

Kline MW, Van Dyke RB, Lindsey JC, et al., and the AIDS Clinical Trials Group 240 Team (Mintz M principal investigator, UMDNJ Clinical Site #2804). A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV,AZT) in children with human immunodeficiency virus infection. Pediatrics 1998;101:214-220.

Report of the Quality Standards Subcommittee of the American Academy of Neurology (Mintz M contributing consultant). Evaluation and management of intracranial mass lesions in AIDS. Neurology 1998;50:21-26.

Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM, Cunningham B, Oleske J, for the Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams (Includes Mintz M). Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected Women. JAMA 1999;281:151-157.

Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR III, Song LY, Dankner WM, Oleske JM, Pediatric AIDS Clinical Trials Group Protocol 219 Team (Includes Mintz M). Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New England Journal of Medicine 2001;345:1522-1528.

Buchacz D, Cervia JS, Lindsey JC, Hughes MD, Seage GR, Danker WM, Oleske JM, Moye J, and for the Pediatric AIDS Clinical Trials Group 219 Study Team (Includes Mintz M). Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics 2001;108:e72.

Gaughan DM, Hughes MD, Seage GR, Selwyn PA, Carey VJ, Gortmaker SL, Oleske JM, PACTG 219 Team (Includes Mintz M). The prevalence of pain in pediatric human immunodeficiency virus/acquired immunodeficiency syndrome as reported by participants in the pediatric late outcomes study PACTG 219. Pediatrics 2002;109:1144- 1152.

Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children convened by the National Pediatric and Family HIV Resource Center, Health Resources and Services Administration, and National Institutes of Health (Mintz M, member). Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, updated November 26, 2003. http://www.aidsinfo.nih.gov/guidelines/default_db2.asp?id=51

Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children convened by the National Resource Center at the François-Xavier Bagnoud Center, UMDNJ; Health Resources and Services Administration; and National Institutes of Health (Mintz M, member). Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, updated November 30, 2004. http://aidsinfo.nih.gov/guidelines/pediatric/PED_113004.html

Book Chapters:

Mintz M. Neurologic Abnormalities. In: Yogev R, Connor EM, eds. Management Of HIV Infection In Infants And Children. 1st ed. St. Louis, MO: Mosby-Year Book Inc., 1992:247-285.

Sharer LR, Mintz M. Neuropathology Of AIDS In Children. In: Scaravilli F, ed. AIDS-The Pathology Of The Nervous System. Berlin: Springer Verlag, 1993:201-214.

Mintz M. Neurological Manifestations And The Results Of Treatment Of Pediatric HIV Infection. In: Fejerman N, Chamoles NA, eds. New Trends In Pediatric Neurology. Amsterdam: Elsevier Science Publishers, Excerpta Medica, 1993:161-168.

Hanna J, Mintz M. Neurological And Neurodevelopmental Functioning In Pediatric HIV Infection. In: Boyd-Franklin N, Steiner GL, Boland M, eds. Children, Families And HIV/AIDS: Psychosocial And Psychotherapeutic Issues. New York: Guilford Press, 1995:30-50.

Mintz M. Neurobehavioral Manifestations Of Pediatric AIDS. In: Frank Y, ed. Pediatric Behavioral Neurology. Boca Raton, Florida: CRC Press, 1996:335-365.

Mintz M. Clinical Features Of HIV Infection In Children. In: Gendelman HE, Lipton S, Epstein L, Swindells SY, eds. The Neurology of AIDS. New York: Chapman and Hall/International Thomson Publishing, 1998:385-407.

Mintz M. HIV-1 Encephalopathy: unique aspects in children and adolescents: Clinical features. In: Gendelman HE, Everall IP, Grant I, Lipton SA, Swindells S, eds. The Neurology of AIDS. 2nd ed. London: Oxford University Press, 2005:639-658.

Mintz M, Allesandri M, Curatolo P. Treatment Approaches for Autistic Spectrum Disorders. In: Tuchman R, Rapin I, eds. Autism: A Neurological Disorder of Early Brain Development, International Child Neurology Association. London: Mac Keith Press, 2006:281-307.

Abstracts:

Mintz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR, Epstein LG. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. (Presented at the Satellite Conference of the Fifth International AIDS Conference: Neurological and Neuropsychological Complication of HIV Infection, Quebec, Canada; June 2, 1989.)

Mintz M, Rapaport R, Oleske, J.M., Connor, E.M., Koenigsberger, M.R., Denny, T., Epstein, L.G. Elevated circulating tumor necrosis factor levels are associated with neurologic deterioration, but not cachexia, in children with AIDS. (Presented at the Fifth Annual National Pediatric AIDS Conference, Los Angeles, California; September 7, 1989.)

Mintz M, Oleske JM, Connor EM, Sharer LR, Koenigsberger MR, Epstein LG. Neurological manifestations of AIDS in a large cohort of children. (Presented at the Fifth Annual National Pediatric AIDS Conference, Los Angeles, California; September 7, 1989.)

Mintz M, Epstein LG, Koenigsberger MR. Idiopathic childhood stroke is associated with human leukocyte antigen (HLA)-B51. Annals of Neurology 1989;26:470. (Presented at the Eighteenth Annual Child Neurology Society Meeting, San Antonio, Texas; October 14, 1989.)

Chatkupt S, Mintz M, Epstein LG, Bhansali D, Koenigsberger MR. Neuroimaging studies in children with Human immunodeficiency virus type 1 infection. Annals of Neurology 1989;26:453. (Presented at the Eighteenth Annual Child Neurology Society Meeting, San Antonio, Texas; October 13, 1989.)

Haiken H, Hernandez M, Mintz M, Boland M. School aged HIV-infected children and access to education. (Presented at the Sixth International Conference on AIDS, San Francisco, California, June 22-24, 1990.)

Mintz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR, Epstein LG. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. AIDS Scan 1990;1(3).

Mintz M, Connor EM, Oleske JM, Bryant BJ, Ayala CI, Brown-Colabelli N, Burroughs Wellcome Co., NIH/NIAID AIDS Clinical Trials Group Protocol #043. Neurologic deterioration in children on long-term zidovudine therapy. (Presented at the Ninth AIDS Clinical Trials Group Meeting, Bethesda, Maryland, July 10-13, 1990.)

O'Donnell K, Maha M, McKinney R, Mintz M, Brouwers P, Connor EM, Feinberg J, Scott GB, Wilfert C. Neurodevelopmental improvement with oral zidovudine in children with advanced HIV disease. (Presented at the Society for Research in Child Development, April 18, 1991.) O'Donnell K, Mintz M, Maha M, McKinney R, Wilfert C, The Pediatric Zidovudine Study Group. Neurodevelopmental (ND) effects of pediatric HIV infection and treatment with oral zidovudine. Pediatric Research 1991;29:181A. (Presented to the Society for Pediatric Research, May, 1991.)

Tudor-Williams G, St. Clair M, McKinney R, Maha M, Mintz M, Walter E, Santacroce S, O'Donnell K, Rudoll T, Wilfert C. Clinical correlates of HIV-1 sensitivity to Retrovir (AZT). Pediatric Research 1991;29:186A. (Presented to the Society for Pediatric Research, May 1991.)

Mintz M, Boland M, O'Hara M, Barbos J, Hansen C, Maha-Elkins M, Sandzhieva D, Esenova V, Oleske J. Pediatric HIV infection in Elista, Russia: interventional strategies. [abstract #POB-3651] (Presented at the VIII International Conference on AIDS/III STD World Congress, Amsterdam, Holland, July 19-24, 1992.)

Sharer LR, Mintz M, Vinters HV, Epstein LG. Vacuolar myelopathy in children with AIDS. (Presented to the IV International Conference on Neuroscience of HIV Infection: Basic and Clinical Frontiers 1992, Amsterdam, Holland, July 15, 1992.)

Mintz M. Pediatric HIV Infection in Elista, Russia: Interventional Strategies. (Presented at the World United Against AIDS: Amsterdam Update conference, UMDNJ-New Jersey Medical School, Newark, N.J.; September 9, 1992.)

Cho E-S, Mintz M, Epstein LG, Sharer LR. Neuropathological effects of antiretroviral therapy in children with HIV-1 infection. Journal of Neuropathology and Experimental Neurology, 1993. (Presented at the American Association of Neuropathologists, Salt Lake City, Utah, June, 1993.)

Mintz M, McSherry G, Hoyt LG, Connor EM, Word BM, Wolansky L, DiCarlo FJ, Oleske JM, Sharer LR. Wernicke's encephalopathy in a child with HIV infection. Clinical Neuropathology 1993;12:S25. (Presented at the Neuroscience of HIV Infection: Basic and Clinical Frontiers 1993, Vienna, Austria, June, 1993.)

O'Donnell K, Mintz M, McKinney R, Wilfert C. Neurodevelopment in children symptomatic with HIV disease: variability and correlates with systemic disease. (Presented at the Society for Research in Child Development, New Orleans, 1993)

Mintz M. Therapeutic interventions in HIV infection. Developmental Medicine and Child Neurology 1995;37(Suppl. No. 72):86. (Presented at the European Pediatric Neurology Society, Eilat, Israel, 1995)

Oleske JM, Culnane M, Fowler MG, Rubin-Hale A, Brady M, Mofenson L, Clark C, ACTG 219 Team (Includes Mintz M). AIDS Clinical Trial Groups Protocol 219: A Pediatric Late Outcomes Protocol. (Presented At The IDSA National Conference, San Francisco, 1995)

Goodman MH, Kubichek M, Mintz M, Bigos D, Festa C, Doolin E. Indwelling percutaneous intravenous catheter use for intractable epilepsy management. (Presented at the Eighth Annual Pediatric Critical Care Colloquium, Sea Island, Georgia, 1995)

Mintz M, Tardieu M, Hoyt L, Mendelson J, McSherry G, Oleske JM. Levodopa therapy improves motor function in HIV-infected children. Journal Of Neurovirology, 1996. (Presented At The Neuroscience Of HIV Infection: Basic Research And Clinical Frontiers, Paris, France, March, 1996)

Trapani C, Treadwell K, Leventhal BL, Mintz M, Bruce S, Audette M. Considering the relationship between neurological and environmental antecedents to aggressive behavior: an interdisciplinary approach to the assessment and treatment of a severely traumatically brain injured youth. (Presented at the International Conference for the Association for Behavior Analysis, 1997)

Mintz M, Blumenfeld S. Fluoxetine treatment in children and adolescents with Asperger’s syndrome. Annals of Neurology 1999;45:529. (Presented at the 28th Annual Meeting of the Child Neurology Society, Nashville, Tennessee, October, 1999)

Ryan SG, George RH, Brooks-Kayal AR, Brown L, Bergqvist CA, Clancy RR, Dlugos DJ, Mintz M, Bingham P, Berman P, Ferraro T, Buono R. Association studies in absence epilepsy. Epilepsia 2000;41(suppl 7):74. (presented at the American Epilepsy Society meeting, 2000)

Mintz M, Blumenfeld S, Hanway-Alberts L, Graner CA, Fisher J. Metabolic acidosis induced by topiramate: response to bicarbonate supplementation. (Presented at the 53rd Annual Meeting of the American Academy of Neurology, Philadelphia, Pennsylvania, May, 2001)

Mintz M, Graner CA, Blumenfeld S, Alberts L. Levetiracetam monotherapy in pediatric patients. Epilepsia 2002 (Presented at the American Epilepsy Society Meeting, Seattle, Washington, 2002)

Alberts L, Blumenfeld S, Graner CA, DeGaetano M, Scornaienchi J, Mintz M. Oxcarbazepine for the treatment of behavior/mood disorders in children. Annals of Neurology 2003;54 (suppl 7):S148. (Presented at the 32nd Annual Meeting of the Child Neurology Society, Miami, Florida, October, 2003)

Lewis D, Linder S, Kurlan R, Winner P, Dunn D, Sallee FR, Dure L, Erenberg G, Mintz M, Milton D, Schuh K, Allen AJ, Kelsey D. Atomoxetine for the treatment of attention deficit hyperactivity disorder and comorbid tics in children. Annals of Neurology 2003;54(suppl 7):S106. (Presented at the 32nd Annual Meeting of the Child Neurology Society, Miami, Florida, October, 2003)

Glauser TA, Gauer LJ, Chen L and LEV N159 Pediatric Study Group [includes Mintz M]. Multicenter, double-blind, placebo-controlled trial of adjunctive levetiracetam (Keppra®) therapy (up to 60mg/kg/day) in pediatric patients with refractory partial epilepsy. Epilepsia 2004; 45(suppl 7):186 (Presented as a platform presentation at the Annual Meeting of the American Epilepsy Society, New Orleans, Louisiana, December, 2004)

Mintz M: Neurologic basis of autism: Effective educational and pharmacological interventions. Neuropediatrics 2006;37 (Suppl 1). (Presented as a symposium presentation at the 10th International Child Neurology Congress, Montreal, Canada, June, 2006)

Spencer TJ, Sallee FR, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Gilbert DL, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M, Milton DR, Feldman PD, Kelsey DK. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. Neuropediatrics 2006; (Suppl 1). (Presented as a symposium presentation at the 10th International Child Neurology Congress, Montreal, Canada, June 13, 2006)

Spencer TJ, Sallee FR, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Gilbert DL, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M, Milton DR, Feldman PD, Kelsey DK. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. 2006 Book of Scientific Proceedings. (Presented at the Annual Meeting of the American Academy of the American Child and Adolescent Psychiatry (AACAP), San Diego, California, October 24-29, 2006)

Mintz M, LeGoff D, Scornaienchi J, Levin S, Mintz P, Smith C. The Effects of Levetiracetam on Neuropsychological Functioning in Relation to “Subclinical” Spike Production. Epilepsia 2006;Volume 47, S4: 112. (Presented as a poster presentation at the Annual Meeting of the American Epilepsy Society, San Diego, California, December, 2006)

Spencer TJ, Sallee FR, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Gilbert DL, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M, Dure LS, Milton DR, Feldman PD, Trzepacz PT, Kelsey DK. Atomoxetine treatment of ADHD in children with comorbid Tourette Syndrome. (Presented at the 13th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP),[S.1.62] Florence, Italy, August 25-29, 2007.)

Mintz M, Hunter S, Yang H, Schiemann J, Jones J, Stalvey T, and the LEV N01103 Pediatric Study Group. Double-blind, placebo-controlled, non-inferiority study to evaluate the cognitive and neuropsychological effects of levetiracetam 20-60 mg/kg/day as adjunctive treatment vs. placebo in pediatric patients with partial onset seizures. (Presented at the American Epilepsy Society 61st Meeting, December 2, 2007)

Ronen GM, Lach L, Streiner DL, Verhey LH, Boyle MH, Cunningham CE, Rosenbaum PI, North-American Pediatric Epilepsy-HRQL Research Group [includes Mintz M]. Exploring predictors of quality of life in childhood epilepsy. Annals of Neurology 2008 (Presented at the 37th Annual Meeting of the Child Neurology Society, Santa Clara, California, 2008)

Kapetanovic S, Aaron L, Montepiedra G, Williams P, Sirois P, Malee K, Garvie P, Nichols S, Kammerer B, Pearson D, Farley J, Mintz M and James M. Oleske, for the IMPAACT DACS 642 Team. Relationships between Use of Antipsychotics and Changes in Physical Growth in Children and Adolescents with HIV. (Presented at the American Psychiatric Association Annual Meeting in San Francisco, May 18, 2009)

Reports/Reviews:

Mintz, M: Pediatric HIV Infection in Romania. Romanian Orphans' Social and Education Support Project (ROSES), a project of World Vision Relief and Development, derived from a site visit to Romania, 12/3/90-12/11/90.

Mintz, M (Participant): Report of the Task Force on Medical Rehabilitation Research, National Institutes of Health, June, 1990.

Mintz, M: Report of the Medical Mission to Elista, Russia. Francois-Xavier Bagnoud Pediatric HIV International Training Program, derived from a site visit to Russia, 9/20/91-9/29/91.

Mintz, M: Strategy for Treatment of HIV-infected Children in Romania. Romanian Orphans' Social and Education Support Project (ROSES), a project of World Vision Relief and Development, derived from a site visit to Romania, 11/23/91-11/29/91.

Mintz, M: Evaluation and assessment of the World Vision International "Children with HIV/AIDS Project" a project of World Vision Relief and Development and United States of America International Development agency, derived from a site visit to Romania, 11/8/93-11/17/93.

Mintz, M: Children's Hospital Of New Jersey Newsletter: Status Epilepticus;15: Review #9, 1990; Phenobarbital For Febrile Seizures;15: Review #4, 1990; Seizure Recurrence After A First Febrile Seizure;17:Review #6, 1992.

Mintz, M: DigiTrace Care Services, EEG Case of the Month, July 1998 and January 1999.

Mintz, M: Vaccines and autism: Is there a link? Innovations 2001;1(1):2-3.

Mintz, M: New epilepsy treatments offer more hope. Innovations 2002;1(2):3.

Mintz, M: Exercise can benefit the brain. Innovations 2002;1(3):1-3.

Mintz M, LeGoff D: Autism 101: What are the possible causes, features and treatments of this disorder? NJEA Review 2009; 82(9):16-18.